title: Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
abstract: Mesenchymal stem cells have demonstrated immunomodulatory capabilities as well as modest efficacy in animal models of joint injury, warranting further study as a potential treatment of joint disease. The goal of the study was to investigate the blood and synovial immune and histologic response to intra-articular injection of autologous, allogeneic, and xenogeneic bone marrow-derived mesenchymal stem cells (MSC) in horses. The study group consisted of 6 five-year-old Thoroughbred mares that had been injected previously with 15 million, genetically modified autologous, allogeneic, or xenogeneic MSC into the fetlock joints. One group of autologous cells was genetically modified to permit MSC biolocalization in the synovium. To assess response to the injection, synovial biopsies were obtained via arthroscopy 60 days after MSC injection for gross, histologic and molecular analyses. Peripheral blood mononuclear cells were isolated from each horse 120 days after MSC injection and co-cultured with a monolayer of each MSC group to permit quantification of activated CD4+ lymphocytes and cytokine release (ELISA) upon re-exposure to MSC. Arthroscopic examination revealed normal synovium with no grossly detrimental effect to the synovium or cartilage. Intra-articular MSC produced a persistent mononuclear infiltrate for at least 60 days, mostly perivascular, identified as CD3+ lymphocytes. An immune response (significant increase in CD4+ lymphocytes) was detected upon re-exposure to xenogeneic but not to allogeneic or autologous MSC. An inflammatory cytokine release from peripheral blood mononuclear cell/MSC co-cultures was present in all MSC groups but was significantly greater in the xenogeneic group. In conclusion, intra-articular injection of MSC, regardless of cell origin, incited a persistent mononuclear synovitis demonstrating a sustained biologic influence of these cells. Allogeneic cells did not elicit a detectable immune response upon re-exposure using our methods.
authors.affiliation: Comparative Orthopedics Research Laboratory, Departments of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, United States.
authors.forename: John H
authors.initials: JH
authors.lastname: Pigott
authors.forename: Akikazu
authors.initials: A
authors.lastname: Ishihara
authors.forename: Maxey L
authors.initials: ML
authors.lastname: Wellman
authors.forename: Duncan S
authors.initials: DS
authors.lastname: Russell
authors.forename: Alicia L
authors.initials: AL
authors.lastname: Bertone
mesh_terms: D000818:Animals; D001182:Arthroscopy; D005260:Female; D006736:Horses; D007111:Immunity, Cellular; D007270:Injections, Intra-Articular; D015850:Interleukin-6 / Q000096:biosynthesis; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000502:physiology; D013583:Synovial Membrane / Q000276:immunology* / Q000473:pathology; D013585:Synovitis / Q000209:etiology; D014182:Transplantation, Autologous; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
chemical_list: D015850:Interleukin-6
keywords: Allo; Allogeneic; Auto; Auto-BMP2; Autologous; BMDMSC; BMP2; Horse; Immune; Intra-articular; MSC; Stem cell; Xeno; allogeneic mesenchymal stem cells; autologous mesenchymal stem cells; autologous mesenchymal stem cells genetically modified to secrete human bone morphogenetic protein 2; bone marrow-derived mesenchymal stem cells; bone morphogenetic protein 2; mesenchymal stem cells; xenogeneic mesenchymal stem cells